Iguana Healthcare Management’s Cymabay Therapeutics CBAY Stock Holding History

Iguana Healthcare Management’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-250,000	Closed	-$2.02M	–	75
2017 Q3	$2.02M	Buy	250,000 +145,000	+138%	+$980K	1.1%	35
2017 Q2	$605K	Buy	+105,000	New	+$447K	0.34%	55
2015 Q4	–	Sell	-250,000	Closed	-$485K	–	86
2015 Q3	$485K	Buy	250,000 +10,000	+4%	+$27.2K	0.19%	70
2015 Q2	$646K	Sell	240,000 -260,000	-52%	-$1.07M	0.2%	62
2015 Q1	$3.46M	Buy	500,000 +375,000	+300%	+$3.6M	1.46%	25
2014 Q4	$1.23M	Hold	125,000	–	–	0.59%	47
2014 Q3	$855K	Buy	+125,000	New	+$768K	0.46%	51

Other funds holding CBAY

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Iguana Healthcare Management's CBAY Position: Q4 2017 in Review

Iguana Healthcare Management sold out of Cymabay Therapeutics (CBAY) in Q4 2017, closing a stake of 250,000 shares — an estimated $2.02M sold.

Iguana Healthcare Management first reported a position in CBAY in Q3 2014 and held it in 7 quarters. The position peaked at $3.46M in Q1 2015. 80 funds tracked by Wall St. Rank hold CBAY as of Q4 2017.

Iguana Healthcare Management reported no remaining Cymabay Therapeutics position as of Q4 2017 after selling out during the quarter.
Iguana Healthcare Management sold 250,000 Cymabay Therapeutics shares in Q4 2017, an estimated $2.02M.
Iguana Healthcare Management first reported a position in Cymabay Therapeutics in Q3 2014 and held it in 7 quarters.
Iguana Healthcare Management's Cymabay Therapeutics position peaked at $3.46M in Q1 2015.
80 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q4 2017.

Based on Iguana Healthcare Management's 13F filing for Q4 2017, filed 14 Feb 2018.